Which biotech company received FDA approval for a gene therapy targeting a rare

Practice Questions

Q1
Which biotech company received FDA approval for a gene therapy targeting a rare genetic disorder in 2022?
  1. Bluebird Bio
  2. Novartis
  3. Sarepta Therapeutics
  4. Spark Therapeutics

Questions & Step-by-Step Solutions

Which biotech company received FDA approval for a gene therapy targeting a rare genetic disorder in 2022?
  • Step 1: Identify the year in question, which is 2022.
  • Step 2: Look for biotech companies that received FDA approval in 2022.
  • Step 3: Focus on gene therapies that target rare genetic disorders.
  • Step 4: Find the specific company that received this approval.
  • Step 5: Confirm that Spark Therapeutics is the company that received FDA approval for its gene therapy.
No concepts available.
Soulshift Feedback ×

On a scale of 0–10, how likely are you to recommend The Soulshift Academy?

Not likely Very likely